Saba Capital Management, L.P. bought HQL
May 31, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 21,369 shares of Abrdn Life Sciences Investors at $13.29 per share, a transaction worth $284.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,369
Price
$13.29
Total value
$284.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 31, 2024
Filing dateJune 3, 2024
Shares owned after3,320,668
OwnershipIndirect
10b5-1 planNo
AmendedNo